NANO-X Faces New Israeli Lawsuit Over Previously Dismissed US Claims

Ticker: NNOX · Form: 6-K · Filed: Jan 2, 2024 · CIK: 1795251

Complexity: simple

Sentiment: mixed

Topics: litigation, legal-risk, international-lawsuit

TL;DR

**NANO-X is being sued again in Israel for old claims already thrown out by a US court, but they're confident they'll win.**

AI Summary

Nano-X Imaging Ltd. (NANO-X) announced on January 2, 2024, that a claim was filed in Israel against the company, Nano-x Imaging PLC (Nanox Gibraltar), and Chairman Ran Poliakine. This claim, seeking approximately $1 million in unpaid consulting fees and $29.5 million in warrants, is based on allegations previously dismissed by a U.S. court on October 28, 2021. This matters to investors because it represents a new legal challenge in a different jurisdiction for claims the company believes are meritless, potentially incurring legal costs and creating uncertainty, even if the company is confident in its position.

Why It Matters

This new lawsuit in Israel, despite being based on previously dismissed U.S. allegations, could lead to additional legal expenses and reputational risk for Nano-X Imaging Ltd., potentially impacting its stock price.

Risk Assessment

Risk Level: medium — While the company is confident and the claims were dismissed in the U.S., any new lawsuit, especially in a different jurisdiction, introduces legal costs and uncertainty, making it a medium risk.

Analyst Insight

An investor should monitor the progress of this Israeli lawsuit for any unexpected developments, but given the prior U.S. dismissal and the company's confidence, the immediate impact might be limited to legal costs rather than a significant financial liability.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What is the primary reason for the new claim filed against Nano-X Imaging Ltd. in Israel?

The new claim in Israel is based on allegations of breach of a consulting agreement from 2015 between the plaintiff and Nanox Gibraltar, demanding approximately $1 million in unpaid consulting fees and $29.5 million related to claimed entitlement to warrants in Nanox Gibraltar.

Who are the specific parties named as defendants in the Israeli lawsuit?

The defendants named in the Israeli lawsuit are Nano-X Imaging Ltd., Nano-x Imaging PLC (Nanox Gibraltar), and Mr. Ran Poliakine, the Company's Chairman.

What was the outcome of the previous U.S. lawsuit concerning these allegations?

The previous U.S. lawsuit, filed on October 28, 2021, in the United States District Court for the Central District of California, was dismissed, meaning the allegations were rejected by the U.S. court.

What is Nano-X Imaging Ltd.'s stance on the merit of the new Israeli claims?

Nano-X Imaging Ltd. categorically rejects the meritless claims against the Company and is confident in its position, stating that the allegations were previously dismissed by a U.S. court.

When was the consulting agreement, central to the plaintiff's allegations, originally entered into?

The consulting agreement between the plaintiff and Nanox Gibraltar, which is central to the allegations, was entered into in 2015.

Filing Stats: 575 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2024-01-02 08:30:02

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NANO-X IMAGING LTD . By: /s/ Ran Daniel Name: Ran Daniel Title: Chief Financial Officer Date: January 2, 2024 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing